ChampionX Corp has a consensus price target of $35.67 based on the ratings of 9 analysts. The high is $51 issued by Barclays on April 4, 2024. The low is $22 issued by B of A Securities on July 15, 2022. The 3 most-recent analyst ratings were released by Piper Sandler, Piper Sandler, and Barclays on July 15, 2024, April 8, 2024, and April 4, 2024, respectively. With an average price target of $41.33 between Piper Sandler, Piper Sandler, and Barclays, there's an implied 32.78% upside for ChampionX Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for ChampionX (NASDAQ:CHX) was reported by Piper Sandler on July 15, 2024. The analyst firm set a price target for $33.00 expecting CHX to rise to within 12 months (a possible 6.01% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for ChampionX (NASDAQ:CHX) was provided by Piper Sandler, and ChampionX maintained their neutral rating.
The last upgrade for ChampionX Corp happened on October 17, 2023 when Barclays raised their price target to N/A. Barclays previously had an equal-weight for ChampionX Corp.
The last downgrade for ChampionX Corp happened on January 8, 2024 when Piper Sandler changed their price target from $38 to $32 for ChampionX Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChampionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChampionX was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
While ratings are subjective and will change, the latest ChampionX (CHX) rating was a maintained with a price target of $40.00 to $33.00. The current price ChampionX (CHX) is trading at is $31.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.